After studying chemistry at the University of Zurich, Switzerland, Dr. Ruprecht received a Ph.D. in human genetics from Columbia University, New York, and an M.D. from the University of Miami School of Medicine, Florida. She completed training in internal medicine at the UCLA, and in hematology/oncology at the Memorial Sloan-Kettering Cancer Center in New York. In 1984, she joined the Dana-Farber Cancer Institute (DFCI) in Boston, Massachusetts. Currently, Dr. Ruprecht is Professor of Medicine at Harvard Medical School and the DFCI. In 2001, she received an Honorary Professorship from the Institute of Medical Biology, Chinese Academy of Medical Sciences, Peking Union Medical College, People’s Republic of China.  

Dr. Ruprecht directs a multi-institutional AIDS research program that involves collaborators in the United States, Europe, and Africa. Her expertise is in lentiviral pathogenesis and AIDS vaccine development. She has served as consultant for World Health Organization, as member of the National Institute of Allergy and Infectious Diseases (NIAID) AIDS Research Advisory Committee and the NIAID Council, and as scientific advisory board member for a number of organizations. Currently, she is a member of the US-Japan AIDS Panel and of the scientific advisory boards of the American Foundation for AIDS Research, the Washington National Primate Research Center, and the National Cancer Institute’s Vaccine Branch.